BIOAFFINITY TECHNOLOGIES INC's ticker is and the CUSIP is 09076W109. A total of 13 filers reported holding BIOAFFINITY TECHNOLOGIES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $9,968 | +47.4% | 4,615 | +37.9% | 0.00% | – |
| Q1 2024 | $6,761 | +55.2% | 3,347 | +13.0% | 0.00% | – |
| Q4 2023 | $4,356 | -7.6% | 2,961 | -26.9% | 0.00% | – |
| Q3 2023 | $4,713 | +86.1% | 4,049 | +192.6% | 0.00% | – |
| Q2 2023 | $2,533 | – | 1,384 | +5436.0% | 0.00% | – |
| Q3 2022 | $0 | – | 25 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Creative Planning | 12,095 | $22,134 | 0.00% |
| WELLS FARGO & COMPANY/MN | 36 | $66 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 95 | $174 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 21,842 | $39,971 | 0.00% |
| CAPTRUST FINANCIAL ADVISORS | 43,642 | $79,865 | 0.00% |
| Tower Research Capital LLC (TRC) | 1,384 | $2,533 | 0.00% |
| STATE STREET CORP | 17,600 | $32,208 | 0.00% |